GILL PHARMA CONSULT LIMITED

Company Information
for the year from 1 June 2025 to 31 May 2026


Director	GILL, Aaron Singh


Registered Number	15723977 (England and Wales)

Balance Sheet as at
31 May 2026

	2026 £	2025 £
Assets
Fixed Assets	1,546	1,484
Current Assets	100,828	63,449
	102,374	64,933
Capital, Reserves and Liabilities
Capital and reserves	69,544	23,799
Creditors amounts falling due within one year	32,830	39,424
Accruals and deferred income	-	1,710
	102,374	64,933

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The Director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
Average number of employees
The average number of persons employed by the company in the period was 1 (previous period: 1).

The financial statements were approved and authorised for issue by the Director on 8 June 2026, and are signed on its behalf by:

GILL, Aaron Singh
Director
Registered Company No. 15723977